- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02384824
Delayed Plaque Morphology in Patients With STEMI After Thrombus Aspiration During Primary PCI (STEMI-OCT)
Evaluation of Delayed Plaque Morphology by Optical Coherence Tomography (OCT) in Patients With Acute ST Segment Elevated Myocardial Infarction (STEMI) After Thrombus Aspiration During Primary Percutaneous Intervention (PCI)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Current guideline for treating acute STEMI is primarily PCI and stent placement in the infarct-related coronary artery. But, the underlying plaque morphology is not routinely identified due to the limited resolution of conventional imagine modalities. However, autopsy studies have shown that there are different atherosclerotic plaque morphologies involving in acute thrombotic occlusion of coronary arteries other than atherosclerotic plaque rupture, such as plaque erosion, calcified nodule, etc. Some studies have suggested that PCI and stenting might not always be necessary in about 30 - 40% of ACS patients, and an alternative treatment strategy is needed for these patients based on the characteristics of plaque morphology.
100 subjects who meet the inclusion/exclusion criteria will undergo emergent angiography and followings: If no thrombus was observed, OCT examination will be performed in the target vessel;
If thrombosis was confirmed, the subject will undergo manual aspiration thrombectomy and antiplatelet therapy, and TIMI flow will be assessed:
If TIMI flow grade < 3, the subject will receive stent implantation as the standard of care followed by OCT examination; If TIMI flow grade of 3, the subject will not receive stent implantation but will be sent to CCU for monitoring and antiplatelet treatment, and have a repeat angiography and OCT examination at Day 7; within the 7days post STEMI, ischemia-driven angiography and/or PCI are allowed, and an OCT examination will be performed in these subject before PCI.
Patients without undergoing initial stent implantation will have scheduled 30-day and 12-month follow-ups for clinical outcomes.
Study Type
Enrollment (Anticipated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Clinical inclusion criteria:
- Age > 18 years
- Onset of STEMI > 30 minutes, but < 12 hours
- ST segment elevation in at least 2 contiguous leads of≥ 1mm or newly developed LBBB on ECG
- Willing and able to provide informed consent
Angiographic inclusion criteria:
- Having at least one infarct-related coronary artery, of which
- The Culprit lesion is suitable for stenting;
- The reference diameter of culprit vessel is ≥ 2.5 mm but ≤ 4 mm;
- The TIMI flow is ≤ 1 in culprit lesion segment prior to guide wire crossing
- No excessive tortuosity and calcification in the culprit lesion segment that allowing stent implantation
Exclusion Criteria:
1. Clinical exclusion criteria:
- Contraindicating to any concomitant study medications
- Having cardiogenic shock with hemodynamic instability
- A history of bleeding diathesis or known coagulopathy
- A history of cerebrovascular accident (CVA) or transient ischemic attack (TIA) within the past 6 months; or a history of intracranial tumor, aneurysm or arteriovenous malformations; or a history of active peptic ulcer or active gastrointestinal (GI) bleeding within the past 2 months; or planned major procedure within 6 weeks; or known platelet count < 100,000 /mm3 or Hb < 10 g/dL
- Planned surgery which may cause discontinuation of ADP-receptor antagonist
- Other serious illness (e.g., cancer) that may reduce life expectancy to less than 1 year
Repeated MI within 7 days of hospitalization for acute MI
Angiographic exclusion criteria:
- Bifurcated lesion unable to identify the culprit lesion
- The culprit lesion is located in the left main artery
- Diffusive lesions without distinguishable culprit lesion
- Previous stent implantation in the culprit lesion segment or STEMI caused by stent thrombosis
- Likely CABG procedure within 30 days
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
plaque morphology by OCT
Time Frame: at the 7th day post PCI/aspiration thrombectomy
|
at the 7th day post PCI/aspiration thrombectomy
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Re-hospitalization due to cardiac symptoms
Time Frame: 30 days & 12 months
|
30 days & 12 months
|
Myocardial infarction related to the target vessel
Time Frame: 30 days & 12 months
|
30 days & 12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SAHZJU CT003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myocardial Infarction
-
Azienda ULSS 5 PolesanaUniversity of PadovaUnknownMyocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Italy
-
University Medical Centre LjubljanaCompletedCardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)Slovenia
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SANot yet recruiting
-
Stiftung Institut fuer HerzinfarktforschungGlaxoSmithKline; University Hospital Muenster; Klinikum NürnbergCompletedMyocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial InfarctionGermany
-
Bispebjerg HospitalOdense University Hospital; Zealand University Hospital; Hvidovre University... and other collaboratorsRecruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Denmark
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Boston Scientific CorporationActive, not recruitingST Elevation Myocardial Infarction | Non ST Elevation Myocardial InfarctionCanada
-
University of LeedsUniversity College, LondonCompletedST-elevation Myocardial Infarction | Non ST-elevation Myocardial Infarction
-
Karolinska InstitutetUppsala University; The Swedish Research CouncilActive, not recruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial InfarctionSweden
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; University Hospital of North... and other collaboratorsActive, not recruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial InfarctionNorway
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom
Clinical Trials on Primary Percutaneous Intervention
-
Assiut UniversityNot yet recruiting
-
University College, LondonNational Institute for Cardiovascular Outcomes Research; British Cardiovascular... and other collaboratorsCompletedPercutaneous Coronary InterventionUnited Kingdom
-
Second Affiliated Hospital, School of Medicine,...Zhejiang University; First Affiliated Hospital of Wenzhou Medical University; Taizhou First People's Hospital and other collaboratorsAvailableST Elevation Myocardial InfarctionChina
-
John PernowCompletedMyocardial Infarction | Coronary Artery DiseaseSweden
-
Assiut UniversityUnknownST Elevation Myocardial Infarction
-
Assiut UniversityUnknownST Segment Elevation Myocardial Infarction
-
Sakarya UniversityCompletedST Elevated Myocardial InfarctionTurkey
-
Instituto Nacional de Cardiologia Ignacio ChavezCompletedMyocardial Infarction, AcuteMexico
-
Ottawa Heart Institute Research CorporationCompleted
-
Assiut UniversityUnknownST Elevation Myocardial InfarctionEgypt